Endoscopic retrograde cholangiopancreatography (ERCP): lessons learned from population-based national registries: a systematic review

Søreide, Jon Arne; Karlsen, Lars Normann; Sandblom, Gabriel; Enochsson, Lars

doi:10.1007/s00464-019-06734-w

Cited by 10 publications

(9 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some researchers have asserted that LC within 7 d after ERCP could eliminate 76% of recurrent biliary complications (20)(21)(22). The comparative results of this study showed that LC at 1-3 d after ERCP was associated with fewer perioperative complications, lower long-term incidences of angiocholitis and bile duct stricture, and better prognoses, which are consistent with the results of a previous study (12).…”

Section: ' Discussionsupporting

confidence: 90%

Effects of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography on liver, bile, and inflammatory indices and cholecysto-choledocholithiasis patient prognoses

Gao¹,

Jiang²

2021

Clinics

View full text Add to dashboard Cite

show abstract

Section: ' Discussionsupporting

confidence: 90%

Effects of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography on liver, bile, and inflammatory indices and cholecysto-choledocholithiasis patient prognoses

Gao¹,

Jiang²

2021

Clinics

View full text Add to dashboard Cite

show abstract

“…5 Evidence of infection was reported in 5% of 1177 patients followed prospectively for 30 days after endoscopic retrograde cholangiopancreatography (ERCP) 6 ; an unknown proportion of such infections is caused by patient-to-patient transmission via contaminated devices. Because of the severity of carbapenem-resistant Enterobacteriaceae infections, and because more than 660,000 ERCP procedures are performed annually in the United States 4 and more are performed internationally, [7][8][9][10] even rare duodenoscope cross-contamination should be addressed in hospital infection control programs.…”

mentioning

confidence: 99%

Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography

Muthusamy

Bruno

Kozarek

et al. 2020

Clinical Gastroenterology and Hepatology

View full text Add to dashboard Cite

BACKGROUND & AIMS: Disposable, single-use duodenoscopes might reduce outbreaks of infections associated with endoscope reuse. We tested the feasibility, preliminary safety, and performance of a new single-use duodenoscope in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). METHODS: We conducted a case-series study of the outcomes of ERCP with a single-use duodenoscope from April through May 2019 at 6 academic medical centers. We screened consecutive patients (18 years and older) without alterations in pancreaticobiliary anatomy and enrolled 73 patients into the study. Seven expert endoscopists performed roll-in maneuvers (duodenoscope navigation and visualization of duodenal papilla only) in 13 patients and then ERCPs in the 60 other patients. Outcomes analyzed included completion of ERCP for the intended clinical indication, crossover from a single-use duodenoscope to a reusable duodenoscope, endoscopist performance ratings of the device, and serious adverse events (assessed at 72 hours and 7 days). RESULTS: Thirteen (100%) roll-in maneuver cases were completed using the single-use duodenoscope. ERCPs were of American Society for Gastrointestinal Endoscopy procedural complexity grade 1 (least complex; 7 patients [11.7%]), grade 2 (26 patients [43.3%]), grade 3 (26 patients [43.3%]), and grade 4 (most complex; 1 patient [1.7%]). Fifty-eight ERCPs (96.7%) were completed using the single-use duodenoscope only and 2 ERCPs (3.3%) were completed using the single-use duodenoscope followed by crossover to a reusable duodenoscope. Median overall satisfaction was 9 out of 10. Three patients developed post-ERCP pancreatitis, 1 patient had post-sphincterotomy bleeding, and 1 patient had worsening of a preexisting infection and required rehospitalization. CONCLUSIONS: In a case-series study, we found that expert endoscopists can complete ERCPs of a wide range of complexity using a single-use duodenoscope for nearly all cases. This alternative might decrease ERCP-related risk of infection. Clinicaltrials.gov no: NCT03701958.

show abstract

“…A systematic review with a total of 6,505 patients from 15 studies concluded 4.58% bleeding rate, 3.68% PEP rate, and 1.93% cholangitis, and a higher overall rate of adverse events in cirrhosis patients with a pooled OR of 1.63 (higher bleeding rate with OR of 2.05 and PEP with OR of 1.33) [9]. Another systematic review based on 31 studies showed a high technical success rate more than 90% [10]. In our study, the overall adverse event rate was 15.3% (including 3.8% (5/131) cholangitis, 4.6% (6/131) PEP and 2.3% (3/131) bleeding) and the rate of ACLF was 4.5% only in ERCP group.…”

Section: Discussionmentioning

confidence: 99%

Safety and Efficacy of Common Endoscopic Treatments in Patients with Decompensated Liver Cirrhosis

Yang

2021

Preprint

View full text Add to dashboard Cite

BackgroundThe safety and efficacy has always been a concern, when patients with decompensated liver cirrhosis (DLC) receive endoscopic treatments. Methods We performed a retrospective study to evaluate the safety and efficacy of common endoscopic treatments including endoscopic resection (ER) and endoscopic retrograde cholangiopancreatography (ERCP) applying to patients with DLC. Results81 patients received ER (43 endoscopic mucosal resection (EMR) and 38 endoscopic submucosal dissection (ESD)) and 131 patients were treated by ERCP. There were no significant differences of the rate of degeneration and invariability of Child-Pugh (CP) class and the overall rate of adverse events between two groups (93.8%/8.6% ER vs. 96.2%/15.3% ERCP). Both the degeneration rate of CP class (35.4%) and the rate of adverse events (27.1%) in subgroup C of ERCP group was significantly higher (P=0). The rate of poor outcomes was higher in ERCP group (12.2%) than that in ER group (2.5%) (P=.02). And subgroup C of ERCP group had a higher poor outcome rate (27.1%) (P=0).ConclusionsER and ERCP could remove focal lesions or relieve symptoms induced by targeted diseases without significant changes of CP class. Significant benefits and risks coexisted in CP class C patients with DLC when receiving ERCP.

show abstract

Endoscopic retrograde cholangiopancreatography (ERCP): lessons learned from population-based national registries: a systematic review

Cited by 10 publications

References 68 publications

Effects of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography on liver, bile, and inflammatory indices and cholecysto-choledocholithiasis patient prognoses

Effects of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography on liver, bile, and inflammatory indices and cholecysto-choledocholithiasis patient prognoses

Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography

Safety and Efficacy of Common Endoscopic Treatments in Patients with Decompensated Liver Cirrhosis

Contact Info

Product

Resources

About